查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1400995

肝病治疗市场，按治疗类型、疾病类型、国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测

Liver Disease Treatment Market, by Treatment Type, Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 266 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年肝病治疗市场规模为223,0042万美元，2023年至2030年CAGR为6.42%。

肝病治疗市场动态

肝病患者数的增加推动了市场的成长

肝臟疾病盛行率的增加、饮酒量的增加以及不良的饮食习惯是预期推动肝臟疾病治疗市场成长的主要因素。例如，根据 2021 年 6 月发表在《临床肝病》杂誌上的研究报告，慢性肝病 (CLD) 影响全球近 15 亿人，是全球疾病和死亡的主要原因之一。此外，根据美国肝病研究协会 2021 年 6 月发布的研究，非酒精性脂肪肝病 (NAFLD) 是肝病的主要原因，占肝病病例的 59%，其次是丙型肝炎 (9 %）、B型肝炎（ 29%）和酒精性肝病（ALD）（2%）。此外，2022年10月发表在《临床与分子肝病学》上的一项研究预测，到2040年，全球非酒精性脂肪肝病（NAFLD）的盛行率将达到55.7%。因此，肝病发病率的上升推动了整个产业的发展。

肝病治疗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球肝病治疗市场在预测期内（2023-2030 年）每年将以 6.42% 左右的CAGR成长

由于肝病患者数量的增加推动市场成长，肝病治疗市场预计将以显着的速度成长

根据治疗类型细分，预计抗病毒药物将在 2022 年显示最大的市场份额

根据疾病类型细分，肝炎是 2022 年的主要疾病类型

按地区划分，北美是 2022 年的主要收入来源

肝病治疗市场-細項分析：

全球肝病治疗市场根据治疗类型、疾病类型和地区进行细分。

市场依治疗类型分为：免疫抑制剂、抗病毒药物、免疫球蛋白、疫苗、标靶治疗、皮质类固醇和化疗药物。由于抗病毒药物具有众多优势，该行业支出的大幅增加对该细分市场产生了积极影响。此外，医疗保健成本的上升、公众意识的提高以及乙型肝炎和丙型肝炎患病率的增加是预计支持市场扩张的其他重要方面。

市场依疾病类型分为以下几类：自体免疫疾病、肝炎、非酒精性脂肪肝病（NAFLD）、遗传性疾病、癌症等。由于製药错误、过量饮酒、自体免疫疾病、病毒感染和非酒精性脂肪性肝炎，肝组织的发炎状态在过去几年中显着恶化。

肝病治疗市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。北美地区预计将成长。 2022年，肝病治疗市场将由北美主导。特别是在中国、印度和韩国，对先进和创新肝病治疗药物的需求不断增长，是推动该行业发展的关键因素之一。此外，这种增长背后的主要因素之一可能是 NAFLD 和肝炎的盛行率不断上升、缺乏专业知识以及该地区医疗基础设施薄弱。

肝病治疗市场-竞争格局：

公司透过多种管道销售产品，包括企业网站、电子商务网站、零售商、分销​​商和最终消费者。产品製造商在多个方面竞争，包括产品成本、性能、产品製造、技术、声誉和可用性。企业用来扩大影响力和扩大市场份额的一些主要类型包括新产品发布、分销网络开发、研发支出以及併购。例如，2023 年 1 月，武田 (Takeda) 和 Arrowhead Pharmaceuticals Inc. 发布了实验性 Fazirsiran 用于治疗与 α-1 抗胰蛋白酶缺乏症 (AATD-LD) 相关的肝病的 2 期 SEQUOIA 临床研究的 Topline资料。

最近的发展：

据 Ipsen 称，2023 年 6 月，经 FDA 批准，从 12 个月大开始患有 Alagille 综合征 (ALGS) 的患者现在可以使用 Bylvay (R) (odevixibat) 治疗胆汁淤积性瘙痒。 Bylvay 是一种每日一次、最低限度全身暴露、局部作用的迴肠胆汁酸转运抑制剂 (IBATi)，全身暴露最小。在美国和欧洲，Bylvay 于 2021 年被授权成为首个治疗进行性家族性肝内胆汁淤积 (PFIC) 患者胆汁淤积性瘙痒的药物。对于符合条件的 ALGS 患者，凭处方即可立即获得 Bylvay。

目录

第一章：肝病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按治疗类型分類的肝病治疗市场片段
    • 按疾病类型分類的肝病治疗市场片段
    • 按国家/地区分類的肝病治疗市场片段
    • 按地区分類的肝病治疗市场片段
  • 竞争洞察

第 3 章：半导体记忆体主要市场趋势

  • 肝病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 肝病治疗市场限制
    • 市场限制影响分析
  • 肝病治疗市场机会
  • 肝病治疗市场未来趋势

第 4 章：半导体记忆体产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：肝病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：肝病治疗市场格局

  • 2022 年肝病治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：肝病治疗市场 - 依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 免疫抑制剂
    • 抗病毒药物
    • 免疫球蛋白
    • 疫苗
    • 标靶治疗
    • 皮质类固醇
    • 化疗药物

第 8 章：肝病治疗市场 - 依疾病类型

  • 概述
    • 按疾病类型分類的细分市场份额分析
    • 自体免疫疾病
    • 肝炎
    • 非酒精性脂肪肝（NAFLD）
    • 遗传性疾病
    • 癌症
    • 其他的

第 9 章：肝病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美半导体记忆体主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模和预测（按疾病类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲半导体记忆体主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模与预测（按疾病类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区半导体记忆体主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模与预测（按疾病类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲半导体记忆体主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模与预测（按疾病类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲半导体记忆体主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗类型）
    • 中东和非洲市场规模及预测（按疾病类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 半导体记忆体产业

  • 竞争仪表板
  • 公司简介
    • Vertex Pharmaceuticals
    • Takeda Pharmaceuticals
    • Shire (now part of Takeda Pharmaceuticals)
    • Roche
    • Pfizer
    • Novartis
    • Madrigal Pharmaceuticals
    • Intercept Pharmaceuticals
    • Gilead Sciences
    • Genfit
    • Durect Corporation
    • Conatus Pharmaceuticals
    • Bristol-Myers Squibb
    • Alnylam Pharmaceuticals
    • Allergan

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1959

REPORT HIGHLIGHT

Liver Disease Treatment market size was valued at USD 22,300.42 Million in 2022, expanding at a CAGR of 6.42% from 2023 to 2030.

Treatment for liver disease refers to medical measures taken to control and lessen illnesses that have an impact on the structure or operation of the liver. Depending on the exact liver ailment, several treatment modalities are used, but they often entail modifying one's lifestyle, taking medications, and in extreme circumstances, undergoing surgery or a liver transplant. Hepatitis, cirrhosis, fatty liver disease, and liver cancer are examples of common liver illnesses. Controlling inflammation, treating symptoms, avoiding consequences, and addressing underlying causes are frequently the objectives of treatment. To improve results and maintain liver function, early diagnosis, and prompt treatments are essential.

Liver Disease Treatment Market Dynamics

The rise in the number of people with liver diseases propelled the market growth

The increased prevalence of liver disorders, the rise in alcohol usage, and poor eating habits are the main factors anticipated to propel growth in the market for therapies for liver diseases. For instance, according to a research report that was published in the Clinical Liver Disease journal in June 2021, chronic liver disease (CLD), which affects nearly 1.5 billion people worldwide, is one of the major causes of sickness and mortality globally. Furthermore, according to research published in June 2021 by the American Association for the Study of Liver Diseases, non-alcoholic fatty liver disease (NAFLD) is the leading cause of hepatic illness, accounting for 59% of cases, followed by hepatitis C (9%), hepatitis B (29%), and alcoholic liver disease (ALD) (2%). Furthermore, a research published in Clinical and Molecular Hepatology in October 2022 predicted that by 2040, the prevalence of non-alcoholic fatty liver disease (NAFLD) will be 55.7% worldwide. As a result, rising liver ailments have fueled the industry as a whole.

Liver Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the Global Liver Disease Treatment market is estimated to grow annually at a CAGR of around 6.42% over the forecast period (2023-2030)

The Liver Disease Treatment market is projected to grow at a significant rate due to the rise in the number of people with liver diseases to propel the market growth

Based on Treatment Type segmentation, Antiviral Drugs was predicted to show maximum market share in the year 2022

Based on Disease Type segmentation, Hepatitis was the leading Disease Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Liver Disease Treatment Market- Segmentation Analysis:

The Global Liver Disease Treatment market is segmented on the basis of Treatment Type, Disease Type, and Region.

The market is divided into categories based on Treatment Type: Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, and Chemotherapy Drugs. Positive effects are being produced on the antiviral drug's sub-segment by the significantly increasing expenditures in the sector, largely because of its numerous advantages. Additionally, rising healthcare costs, increased public awareness, and an increase in the prevalence of hepatitis B and C are other significant aspects anticipated to support market expansion.

The market is divided into categories based on Disease Type: Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others. Due to pharmaceutical mistakes, excessive alcohol intake, autoimmune disorders, viral infections, and nonalcoholic steatohepatitis, the inflammatory status of the liver tissue has significantly worsened during the past several years.

Liver Disease Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for Liver Disease Treatments will be dominated by North America. The extensively increasing need for advanced and innovative liver disease therapeutics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of NAFLD and hepatitis, lack of expertise, and the poor healthcare infrastructure in the region.

Liver Disease Treatment Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2023, Topline data from the Phase 2 SEQUOIA clinical research of experimental Fazirsiran for the treatment of liver disease linked to alpha-1 antitrypsin deficiency (AATD-LD) were released by Takeda and Arrowhead Pharmaceuticals Inc.

Recent Developments:

In June 2023, according to Ipsen, individuals with Alagille syndrome (ALGS) starting at 12 months of age can now treat their cholestatic pruritus with Bylvay® (odevixibat), as to an FDA approval. Bylvay is a once-daily, minimally systemically exposed, locally acting ileal bile acid transport inhibitor (IBATi) with minimum systemic exposure. In the United States and Europe, Bylvay was authorized as the first medication for treating cholestatic pruritus in individuals with progressive familial intrahepatic cholestasis (PFIC) in 2021. For qualifying ALGS patients, Bylvay is instantly available with a prescription.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE TREATMENT MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Takeda Pharmaceuticals
  • Shire (now part of Takeda Pharmaceuticals)
  • Roche
  • Pfizer
  • Novartis
  • Madrigal Pharmaceuticals
  • Intercept Pharmaceuticals
  • Gilead Sciences
  • Genfit
  • Durect Corporation
  • Conatus Pharmaceuticals
  • Bristol-Myers Squibb
  • Alnylam Pharmaceuticals
  • Allergan

GLOBAL LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE

  • Immunosuppressants
  • Antiviral Drugs
  • Immunoglobulins
  • Vaccines
  • Targeted Therapy
  • Corticosteroids
  • Chemotherapy Drugs

GLOBAL LIVER DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Autoimmune Diseases
  • Hepatitis
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Genetic Disorders
  • Cancer
  • Others

GLOBAL LIVER DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Liver Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liver Disease Treatment Market Snippet by Treatment Type
    • 2.1.2. Liver Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Liver Disease Treatment Market Snippet by Country
    • 2.1.4. Liver Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Semiconductor Memory Key Market Trends

  • 3.1. Liver Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liver Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liver Disease Treatment Market Opportunities
  • 3.4. Liver Disease Treatment Market Future Trends

4. Semiconductor Memory Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liver Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Liver Disease Treatment Market Landscape

  • 6.1. Liver Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liver Disease Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Immunosuppressants
    • 7.1.3. Antiviral Drugs
    • 7.1.4. Immunoglobulins
    • 7.1.5. Vaccines
    • 7.1.6. Targeted Therapy
    • 7.1.7. Corticosteroids
    • 7.1.8. Chemotherapy Drugs

8. Liver Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Hepatitis
    • 8.1.4. Non-alcoholic Fatty Liver Disease (NAFLD)
    • 8.1.5. Genetic Disorders
    • 8.1.6. Cancer
    • 8.1.7. Others

9. Liver Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Semiconductor Memory Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Semiconductor Memory Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Semiconductor Memory Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Semiconductor Memory Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vertex Pharmaceuticals
    • 10.2.2. Takeda Pharmaceuticals
    • 10.2.3. Shire (now part of Takeda Pharmaceuticals)
    • 10.2.4. Roche
    • 10.2.5. Pfizer
    • 10.2.6. Novartis
    • 10.2.7. Madrigal Pharmaceuticals
    • 10.2.8. Intercept Pharmaceuticals
    • 10.2.9. Gilead Sciences
    • 10.2.10. Genfit
    • 10.2.11. Durect Corporation
    • 10.2.12. Conatus Pharmaceuticals
    • 10.2.13. Bristol-Myers Squibb
    • 10.2.14. Alnylam Pharmaceuticals
    • 10.2.15. Allergan

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Disease Treatment Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Liver Disease Treatment Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Liver Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)